Professor Margaret Hellard is the Head of the Centre for Population Health at the Burnet Institute in Melbourne and Head of Hepatitis Services in the Infectious Diseases Unit at The Alfred Hospital.
Margaret’s principal research interests are in preventing the transmission and improving the management of blood borne viruses and sexually transmitted infections. She has considerable experience in undertaking multidisciplinary community based research involving people who inject drugs (PWID), men who have sex with men and other vulnerable populations.
Margaret is a member of numerous advisory committees and working groups on viral hepatitis and HIV within Australia and globally; most recently she was co-chair of the WHO Guideline Development Group for Hepatitis Testing.
Margaret is a Principal Investigator of the TAP Study, a world first study examining the efficacy hepatitis C treatment as prevention in PWID, using a community based social network approach, and the PRIME Study, a randomised controlled study exploring hepatitis C models of care in the community.